Literature DB >> 10568861

Intraarticular morphine versus dexamethasone in chronic arthritis.

Andreas Stein1, Alexander Yassouridis, Christopher Szopko, Klaus Helmke, Christoph Stein.   

Abstract

Intraarticular morphine inhibits pain after knee surgery without overt toxicity. This study examined intraarticular morphine in chronic arthritis. We undertook a randomized double-blind comparison between intraarticular morphine (3 mg), dexamethasone (4 mg) and saline (3 ml) in 44 patients with chronic inflammatory arthritis or osteoarthritis of the knee. Pain (the primary outcome measure) was assessed at rest and during activity for 6 days using a visual analog scale (VAS) and the McGill pain questionnaire. Before drug injections and on day 6 synovial leukocyte counts (the secondary outcome measure) were taken. During the first 6 h after injection both morphine and dexamethasone significantly reduced VAS and pain rating indices (PRI) in comparison to saline. Both substances also produced a significant reduction of PRI compared to saline during the subsequent 5 days. No patient displayed untoward side effects. Synovial leukocyte counts were lower after morphine than after saline. In conclusion, intraarticular morphine produces analgesia of similar magnitude to dexamethasone and it may have antiinflammatory actions in chronic arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568861     DOI: 10.1016/S0304-3959(99)00156-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  34 in total

Review 1.  Intra-articular therapy in osteoarthritis.

Authors:  I Uthman; J-P Raynauld; B Haraoui
Journal:  Postgrad Med J       Date:  2003-08       Impact factor: 2.401

Review 2.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 3.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

Review 4.  Peripheral opioid analgesia: clinical applications.

Authors:  Jochen Oeltjenbruns; Michael Schäfer
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 5.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 6.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 7.  [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast].

Authors:  H Sprott
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

8.  Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.

Authors:  Irina Vetter; Wei Cheng; Madusha Peiris; Bruce D Wyse; Sarah J Roberts-Thomson; Jie Zheng; Gregory R Monteith; Peter J Cabot
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 9.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

10.  Perineural morphine in patients with chronic ischemic lower extremity pain: efficacy and long-term results.

Authors:  Kader Keskinbora; Isik Aydinli
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.